Literature DB >> 6847266

Visceral leishmaniasis complicating systemic lupus erythematosus.

P J Wallis, C J Clark.   

Abstract

Active systemic lupus erythematosus in a 32-year-old Chinese woman was successfully controlled by plasmapheresis and steroids. However, occult visceral leishmaniasis was uncovered during therapy and responded to appropriate treatment.

Entities:  

Mesh：

Year:  1983        PMID： 6847266      PMCID： PMC1001100          DOI： 10.1136/ard.42.2.201

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  2 in total

1.  Fatal leishmaniasis in renal-transplant patient.

Authors:  A Broeckaert-van Orshoven; P Michielsen; J Vandepitte
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

2.  Current concepts in parasitology. Leishmaniasis.

Authors:  P D Marsden
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245
  2 in total
  8 in total

1.  Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis.

Authors:  Annalisa Celant; Guido Chichino; Barbara Dal Bello; Marco Massarotti; Lorenzo Minoli; Bianca Marasini
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

2.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

3.  Visceral leishmaniasis associated with chronic granulomatous disease.

Authors:  M Mauri Pont; C Sánchez Rodríguez; F Bella Cueto; J Espaulella Panicot; J Homs Brubenga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

4.  Visceral leishmaniasis.

Authors:  S Capell; M Aranda; A Colomé; R López; R Pujol
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

5.  Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

Authors:  H W Murray; M J Oca; A M Granger; R D Schreiber
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Autoantibodies in systemic lupus erythematosus and normal subjects.

Authors:  E Pateraki; E Kaklamani; P Kaklamanis; R Portocalas; A Aessopos
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

7.  Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus.

Authors:  J Braun; J Sieper; K L Schulte; E Thiel; K Janitschke
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

8.  Visceral leishmaniasis in a patient with systemic lupus erythematosus.

Authors:  André Filipe Santos Silva; João Paulo Branco Calheiros Figueiredo Dias; João Miguel Neves Gonçalves Santos Nuak; Francisca Rocha Aguiar; José António Araújo Pinto; António Carlos Eugénio Megre Sarmento
Journal:  IDCases       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.